Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
(Corrections)Consolidated Financial Results for the Six Months Ended September 30, 2025(Under IFRS)
(Correction) Partial Amendment to the “Notice Regarding Revision of Full-Year Financial Forecast”
[Delayed]Notice Regarding Publication of the Investigation Report of the Special Investigating Committee (Public Version as of February 9, 2026)
[Delayed] Notice Regarding Receipt of a Qualified Conclusion in the Interim Review Report on the Interim Consolidated Financial Statements
Notice Regarding the Completion of Submission of the Semi-Annual Report for the Fiscal Year Ending March 31, 2026
Notice Concerning the Formulation of Recurrence Prevention Measures (Outline)
Consolidated Financial Results (Under IFRS)For the Second Quarter of the March 31, 2026 Fiscal Year
Notice Regarding Revision of Full-Year Financial Forecast
Notice Regarding Receipt of the Investigation Report of the Special Investigating Committee (as of February 9, 2026)
Notice Regarding Execution of Commitment Line Agreement
Notice: FY2026/3 Q3 Consolidated Financial Results Summary Disclosure Delayed (Over 45 Days After Quarter-End)
Notice Concerning Change of Director
Notice Regarding Resignation of Representative Director
Notice Regarding Approval for Extension of Filing Deadline for Semi-Annual Securities Report
Notice Regarding Submission of Application for Approval to Extend the Filing Deadline of Semi-Annual Securities Report
Notice Regarding Dividend of Surplus (Interim Dividend)
Notice Regarding the Establishment of the Management Reform Committee
Notice Regarding the Establishment of a Special Investigating Committee(Further Announcement)
Notice Regarding the Establishment of a Special Investigating Committee
(Summary) Notice Regarding the Result of a Tender Offer for Common Shares of Ci Medical Co., Ltd. (Securities Code:3540) and the Changes in Subsidiar